What is Macro Trials?
Macro Trials operates as a specialized facilitator in the clinical research ecosystem, providing a turnkey model for site activation and management. By centralizing operational frameworks, the company effectively bridges the gap between experienced clinicians and the rigorous demands of modern drug development. Their focus on high-quality data collection and rapid patient enrollment addresses the persistent bottlenecks in the pharmaceutical pipeline. Through its commitment to protocol adherence and community-based trial execution, Macro Trials alleviates the administrative burden on investigators, thereby accelerating the delivery of advanced therapies to patients in need.
How much funding has Macro Trials raised?
Macro Trials has raised a total of $6M across 1 funding round:
Angel/Seed
$6M
Angel/Seed (2023): $6M with participation from INITIATE Ventures, villageglobal.com, Healthy VC, Inflict Health, and MBX Capital
Key Investors in Macro Trials
Village Global
Village Global VC is an early-stage venture capital firm that supports startups with funding, mentorship, and access to a network of successful entrepreneurs and investors.
MBX Capital
MBX Capital is a boutique venture capital firm that partners with and creates healthcare and biotechnology companies that are disrupting conventions in service to public health.
INITIATE Ventures
Undisclosed investor participating in the funding round.
What's next for Macro Trials?
With the recent capital injection, Macro Trials is poised to enter a phase of aggressive growth and infrastructure optimization. The strategic roadmap likely involves the expansion of its site network to capture a broader demographic, further enhancing its value proposition to global sponsors. As the company matures, the focus will shift toward integrating advanced data analytics to further improve trial efficiency and site performance. This major enterprise-level funding provides the necessary runway to invest in proprietary operational technologies and talent acquisition, ensuring that Macro Trials remains at the forefront of clinical research innovation while maintaining its high standards for data integrity and patient safety.
See full Macro Trials company page
